Rorick Rimash
Internal Medicine · Latham, NYNPI 1275525370
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,590 and has fallen 97.7% since, to $36 in 2021.
Across 151 payments — averaging $12.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$435
- Johnson & Johnson$216
- Boehringer Ingelheim$188
- Amarin Pharma, Inc.$170
- GSK$160
- Teva Pharmaceuticals USA, Inc.$130
- plus $578 from 14 others
What the payments were for
- Food & beverage$1,870100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 65 | $435 |
| Johnson & Johnson | 8 | $216 |
| Boehringer Ingelheim | 10 | $188 |
| Amarin Pharma, Inc. | 5 | $170 |
| GSK | 23 | $160 |
| Teva Pharmaceuticals USA, Inc. | 4 | $130 |
| AbbVie(2 entities) | 5 | $98 |
| Merck | 7 | $97 |
| Amgen | 5 | $86 |
| Mannkind Corporation | 4 | $64 |
| Pfizer | 4 | $60 |
| Novartis | 3 | $38 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| IBSA Pharma Inc. | 1 | $18 |
| Abbott | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
| Seqirus USA Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$121
- Vascepa$120
- Xultophy 100/3.6$106
How this compares
$1,876 in reported general payments places this provider in the 80th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 12 | $841 |
| Finasteride | 21 | $613 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Latham
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.